Psychiatric concerns in pediatric epilepsy

Child and Adolescent Psychiatric Clinics of North America

Volumn 19, Issue 2, 2010, Pages 371-386

  Bujoreanu, I Simona ^a   Ibeziako, Patricia ^a   DeMaso, David Ray ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Cognitive functioning; Epilepsy; Psychiatric; Psychosocial; Seizures

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ATOMOXETINE; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; METHYLPHENIDATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TOPIRAMATE; TROPAMAX; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; ZONISAMIDE;

ABNORMAL DREAMING; AGGRESSION; AGITATION; AMNESIA; ANGER; ANXIETY; APATHY; ATAXIA; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BIPOLAR DISORDER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMA; COMORBIDITY; CONCENTRATION LOSS; CONFUSION; COORDINATION DISORDER; DEPERSONALIZATION; DEPRESSION; DIZZINESS; DROWSINESS; DRUG FEVER; DRUG INDUCED HEADACHE; ELECTROENCEPHALOGRAPHY; EMOTIONALITY; EPILEPSY; FATIGUE; GAIT DISORDER; HOSTILITY; HUMAN; HYPERACTIVITY; HYPERAMMONEMIC ENCEPHALOPATHY; HYPERKINESIA; INSOMNIA; IRRITABILITY; LETHARGY; MALAISE; MEMORY DISORDER; MENTAL INSTABILITY; MOOD DISORDER; NERVOUSNESS; NEUROPSYCHOLOGY; ONSET AGE; PAIN; PARADOXIC EXCITEMENT; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOPATHY; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QUALITY OF LIFE; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; SLURRED SPEECH; SOCIAL SUPPORT; SOMNOLENCE; SPEECH DISORDER; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; THOUGHT DISORDER; TREMOR; VAGUS NERVE STIMULATION; VISUAL MEMORY; WELLBEING; WORKING MEMORY;

ADOLESCENT; AMINES; ANXIETY DISORDERS; BIPOLAR DISORDER; CHILD; CHILD, PRESCHOOL; CYCLOHEXANECARBOXYLIC ACIDS; CYCLOHEXANOLS; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; MENTAL DISORDERS; NOREPINEPHRINE; SEROTONIN UPTAKE INHIBITORS; VALPROIC ACID; YOUNG ADULT;

EID: 77952863507     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2010.01.001     Document Type: Review

References (85)

1. Epilepsy Foundation of America Available at:, Accessed October 10, 2009. http://www.epilepsyfoundation.org/.
2. Shinnar S., Pellock J.M. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol 2002, 17:S4-17.
3. World Health Organization Available at:, Accessed November 1, 2009. http://www.who.int/en/.
4. MacAllister W.S., Schaffer S.G. Neuropsychological deficits in childhood epilepsy syndromes. Neuropsychol Rev 2007, 17(4):427-444.
5. Martini R. Neurological disease. Textbook of pediatric psychosomatic medicine: mental health consultation with physically ill children 2010, 387-403. American Psychiatric Press Inc, Washington, DC. R.J. Shaw, D.R. DeMaso (Eds.).
6. Commission on Epidemiology of the International League Against Epilepsy Available at:, Accessed November 11, 2009. http://www.ilae-epilepsy.org/.
7. Poduri A., Manicone P.E. Seizures. Comprehensive pediatric hospital medicine 2007, 791-800. Mosby, Philadelphia. L.B. Zaoutis, V.W. Chiang (Eds.).
8. Friedman M.J., Sharieff G.Q. Seizures in children. Pediatr Clin North Am 2006, 53(2):257-277.
9. Nair G.C., Bharucha N.E. Prognosis of pediatric epilepsy. J Pediatr Neurosci 2008, 3:41-47.
10. Berg A.T., Shinnar S., Levy S.R., et al. Early development of intractable epilepsy in children: a prospective study. Neurology 2001, 56(11):1445-1452.
11. Williams J., Sharp G.B. Epilepsy. Pediatric neuropsychology: research, theory, and practice 2000, 47-73. Guilford Press, New York. K.O. Yeates, M.D. Ris, H.G. Taylor (Eds.).
12. Smith M.L., Elliott I.M., Lach L. Memory outcome after pediatric epilepsy surgery: objective and subjective perspectives. Child Neuropsychol 2006, 12(3):151-164.
13. Bagić A., Theodore W.H., Boudreau E.A., et al. Towards a non-invasive interictal application of hypothermia for treating seizures: a feasibility and pilot study. Acta Neurol Scand 2008, 118(4):240-244.
14. Sherman E.M., Connolly M.B., Slick D.J., et al. Quality of life and seizure outcome after vagus nerve stimulation in children with intractable epilepsy. J Child Neurol 2008, 23(9):991-998.
15. Kossoff E.H., Pyzik P.L., Rubenstein J.E., et al. Combined ketogenic diet and vagus nerve stimulation: rational polytherapy?. Epilepsia 2007, 48(1):77-81.
16. Berg A.T., Langfitt J.T., Testa F.M., et al. Residual cognitive effects of uncomplicated idiopathic and cryptogenic epilepsy. Epilepsy Behav 2008, 13(4):614-619.
17. Henkin Y., Sadeh M., Kivity S., et al. Cognitive function in idiopathic generalized epilepsy of childhood. Dev Med Child Neurol 2005, 47(2):126-132.
18. Hamoda H.M., Guild D.J., Gumlak S., et al. Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Expert Rev Neurother 2009, 9(12):1-8.
19. Williams J., Griebel M.L., Dykman R.A. Neuropsychological patterns in pediatric epilepsy. Seizure 1998, 7(3):223-228.
20. van Mil S.G., Reijs R.P., van Hall M.H., et al. Neuropsychological profile of children with cryptogenic localization related epilepsy. Child Neuropsychol 2008, 14(4):291-302.
21. Hamiwka L.D., Wirrell E.C. Comorbidities in pediatric epilepsy: beyond 'just' treating the seizures. J Child Neurol 2009, 24(6):734-742.
22. Kang H.-C., Eun B.-L., Lee C.W., et al. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 2007, 48(9):1716-1723.
23. Donati F., Gobbi G., Campistol J., et al. Oxcarbazepine Cognitive Study Group. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure 2007, 16(8):670-679.
24. Tonekaboni S.H., Beyraghi N., Tahbaz H.S., et al. Neurocognitive effects of phenobarbital discontinuation in epileptic children. Epilepsy Behav 2006, 8(1):145-148.
25. Loring D.W., Meador K.J. Cognitive side effects of antiepileptic drugs in children. Neurology 2004, 62(6):872-877.
26. Aldenkamp A.P., De Krom M., Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003, 44(4):21-29.
27. Aldenkamp A.P., Weber B., Overweg-Plandsoen W.C., et al. Educational underachievement in children with epilepsy: a model to predict the effects of epilepsy on educational achievement. J Child Neurol 2005, 20(3):175-180.
28. Fastenau P.S., Shen J., Dunn D.W., et al. Neuropsychological predictors of academic underachievement in pediatric epilepsy: moderating roles of demographic, seizure, and psychosocial variables. Epilepsia 2004, 45(10):1261-1272.
29. Austin J.K., Caplan R. Behavioral and psychiatric comorbidities in pediatric epilepsy: toward an integrative model. Epilepsia 2007, 48(9):1639-1651.
30. Rutter M., Graham P., Yule W. A neuropsychiatric study in childhood 1970, JB Lippincott, Philadelphia.
31. Ott D., Siddarth P., Gurbani S., et al. Behavioral disorders in pediatric epilepsy: unmet psychiatric need. Epilepsia 2003, 44(4):591-597.
32. Thompson N.C., Osorio I., Hunter E.E. Nonepileptic seizures: reframing the diagnosis. Perspect Psychiatr Care 2005, 41(2):71-78.
33. Paolicchi J.M. The spectrum of nonepileptic events in children. Epilepsia 2002, 43(Suppl 3):60-64.
34. Bhatia M.S., Sapra S. Pseudoseizures in children: a profile of 50 cases. Clin Pediatr 2005, 44(7):617-621.
35. Caplan R., Siddarth P., Gurbani S., et al. Psychopathology and pediatric complex partial seizures: seizure-related, cognitive, and linguistic variables. Epilepsia 2005, 45(10):1273-1281.
36. Dunn D.W., Austin J.K., Perkins S.M. Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures. Dev Med Child Neurol 2009, 51(5):364-372.
37. Bell G.S., Sander J.W. Suicide and epilepsy. Curr Opin Neurol 2009, 22(2):174-178.
38. Høie B., Sommerfelt K., Waaler P.E., et al. The combined burden of cognitive, executive function, and psychosocial problems in children with epilepsy: a population-based study. Dev Med Child Neurol 2008, 50(7):530-536.
39. Caplan R., Siddarth P., Bailey C.E., et al. Thought disorder: a developmental disability in pediatric epilepsy. Epilepsy Behav 2006, 8(4):726-735.
40. Austin J.K., Harezlak J., Dunn D.W., et al. Behavior problems in children before first recognized seizures. Pediatrics 2001, 107(1):115-122.
41. Rodenburg R., Stams G.J., Meijer A.M., et al. Psychopathology in children with epilepsy: a meta-analysis. J Pediatr Psychol 2005, 30(6):453-468.
42. Asato M.R., Manjunath R., Sheth R.D., et al. Adolescent and caregiver experiences with epilepsy. J Child Neurol 2009, 24(5):562-571.
43. Snodgrass S.R., Vedanarayanan V.V., Parker C.C., et al. Pediatric patients with undetectable anticonvulsant blood levels: comparison with compliant patients. J Child Neurol 2001, 16(3):164-168.
44. Kahana S., Drotar S., Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol 2008, 33(6):590-611.
45. Krumholz A. Driving issues in epilepsy: past, present, and future. Epilepsy Curr 2009, 9(2):31-35.
46. Kazak A.E., Kassam-Adams N., Schneider S., et al. An integrative model of pediatric medical traumatic stress. J Pediatr Psychol 2006, 31(4):343-355.
47. Modi A.C. The impact of a new pediatric epilepsy diagnosis on parents: parenting stress and activity patterns. Epilepsy Behav 2009, 14(1):237-242.
48. Izeri P.K., Ozten A., Aker A.T. Posttraumatic stress disorder. Epilepsy Behav 2006, 8:250-255.
49. Williams J., Steel C., Sharp G.B., et al. Parental anxiety and quality of life in children with epilepsy. Epilepsy Behav 2003, 4(5):483-486.
50. Cushner-Weinstein S., Dassoulas K., Salpekar J.A., et al. Parenting stress and childhood epilepsy: the impact of depression, learning, and seizure-related factors. Epilepsy Behav 2008, 13(1):109-114.
51. Rodenburg R., Meijer A.M., Deković M., et al. Family predictors of psychopathology in children with epilepsy. Epilepsia 2006, 47(3):601-614.
52. Blumer D., Montouris G., Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychiatry Clin Neurosci 1995, 7(4):445-456.
53. Camfield C., Camfield P. Twenty years after childhood-onset symptomatic generalized epilepsy the social outcome is usually dependency or death: a population-based study. Dev Med Child Neurol 2008, 50(11):859-863.
54. Sillanpää M., Haataja L., Shinnar S. Perceived impact of childhood-onset epilepsy on quality of life as an adult. Epilepsia 2004, 45(8):971-977.
55. Buelow J.M., Shore C.P. Childhood epilepsy: failures along the path to diagnosis and treatment. Epilepsy Behav 2006, 9(3):440-447.
56. Smith K., Siddarth P., Zima B., et al. Unmet mental health needs in pediatric epilepsy: insights from providers. Epilepsy Behav 2007, 11(3):401-408.
57. American Academy of Child and Adolescent Psychiatry: Child and Adolescent Psychiatrists Champion Child Healthcare Crisis Relief Act. Press release. Available at: Accessed January 3, 2010. http://www.aacap.org/cs/2007_press_releases/child_and_adolescent_psychiatrists_champion_child_healthcare_crisis_relief_act.
58. Bale J.F., Currey M., Firth S., et al. The child neurology workforce study: pediatrician access and satisfaction. J Pediatr 2009, 154(4):602-606.
59. Gupta V.B. The future of developmental behavioral pediatrics. J Dev Behav Pediatr 2005, 26(3):254-255.
60. Goldstein J., Plioplys S., Zelko F., et al. Multidisciplinary approach to childhood epilepsy: exploring the scientific rationale and practical aspects of implementation. J Child Neurol 2004, 19(5):362-378.
61. Buelow J.M., McNelis A. Should every child with epilepsy undergo a neuropsychological evaluation?. Epilepsy Behav 2002, 3(31):210-213.
62. Szigethy E., Noll R.B. Individual psychotherapy. Textbook of pediatric psychosomatic medicine: mental health consultation with physically ill children 2010, 423-438. American Psychiatric Press Inc, Washington, DC. R.J. Shaw, D.R. DeMaso (Eds.).
63. Wagner J.L., Smith G. Psychosocial intervention in pediatric epilepsy: a critique of the literature. Epilepsy Behav 2006, 8(1):39-49.
64. US Food and Drug Administration Antiepileptic drugs and suicidality Available at:, Accessed December 5, 2009. http://www.fda.gov/downloads/Drugs/Drugsafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM192556.pdf.
65. Thome-Suoza M.S., Kuczynski E., Valente K.D. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 2007, 10:417-425.
66. Alper K., Schwartz K.A., Kolts R.L., et al. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007, 62:345-354.
67. Shah G.D., Hirsch L.J. Bitemporal epileptiform discharges induced by bupropion: a case report. Clin Neuropharmacol 2001, 24:304-306.
68. Physicians' desk reference 2007, Thomson Healthcare, Inc, Montvale (NJ), p. 1603-7. 61st edition.
69. Shepherd G. Adverse effects associated with extra doses of bupropion. Pharmacotherapy 2005, 25:1378-1382.
70. Spiller H.A., Ramoska E.A., Krenzelok E.P., et al. Bupropion overdose: a 3-year multi-center retrospective analysis. Am J Emerg Med 1994, 12:43-45.
71. Ipser J.C., Stein D.J., Hawkridge S., et al. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2009, (3). CD005170.
72. Onder E., Tural U., Gokbakan M. Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?. Eur Arch Psychiatry Clin Neurosci 2008, 258:319-323.
73. Hamandi K., Sander J.W. Pregablin: a new antiepileptic drug for refractory epilepsy. Seizure 2006, 15:73-78.
74. Schaller J.L., Thomas J., Rawlings D. Low-dose tiagabine effectiveness in anxiety disorders. MedGenMed 2004, 6(3):8.
75. Gucuyener K., Erdemoglu K., Senol S., et al. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol 2003, 18:109-112.
76. Kaufmann R., Goldberg-Stern H., Shuper A. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities. J Child Neurol 2009, 24:727-733.
77. Wernicke J.F., Holdrige K.C., Jin L., et al. Seizure risk in patients with attention deficit hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol 2007, 49:498-502.
78. Torres A.R., Whitney J., Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 2008, 12:217-233.
79. Feron F.J., Hendriksen J.G., Nicolai J., et al. New-onset seizures: a possible association with clonidine?. Pediatr Neurol 2008, 38:147-149.
80. Farooq S., Sherin A. Interventions for psychotic symptoms concomitant with epilepsy. Cochrane Database Syst Rev 2008, (4). CD006118.
81. Toone B.K. The psychoses of epilepsy. J Neurol Neurosurg Psychiatr 2000, 69(1):1-3.
82. Langosch J.M., Trimble M.R. Epilepsy, psychosis and clozapine. Hum Psychopharmacol 2002, 17(2):115-119.
83. Kudo T., Ishida S., Kubota H., et al. Manic episode in epilepsy and bipolar 1 disorder: a comparative analysis of 13 patients. Epilepsia 2001, 160:430-437.
84. Salpekar J.A., Conry J.A., Doss W., et al. Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder. Epilepsy Behav 2006, 9(2):327-334.
85. Lopez-Larson M., Frazier J.A. Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders. Harv Rev Psychiatry 2006, 14:285-304.